1.
Journal of the ASEAN Federation of Endocrine Societies
;
: 53-56, 2018.
Artigo
em Inglês
| WPRIM
| ID: wpr-961491
RESUMO
@#We present a case of a 27-year-old female with T2 DM who developed allergic reactions after commencement of insulin therapy. Trial with different types of insulin resulted in a series of allergic reactions ranging from urticarial rash to development of angioedema, bronchospasm and anaphylactic shock. She was successfully treated with a modified insulin desensitization protocol using rapid-acting insulin.